| Literature DB >> 26664327 |
Matthew F Kalady1, Brandie Heald2.
Abstract
Approximately 5 to 10% of colorectal cancers develop within a known hereditary syndrome. Specific underlying genetic mutations drive the clinical phenotype and it is imperative to determine the genetic etiology to provide meaningful surveillance and intervention. Recognizing potential patients and families with a hereditary predisposition is the first step in management. Syndromes can be categorized according to polyp burden as polyposis or nonpolyposis. Clinical assessment should start with a personal and family medical history, physical examination, and evaluation for the presence and type of colorectal polyps or cancers. Key information is gained from these simple steps and should guide the specific genetic analysis for diagnosis. Genetic counseling is a critical component to any hereditary colorectal cancer program and should be conducted before genetic testing to provide education about the implications of test results. This review focuses on the thought process that drives initial clinical evaluation and guides genetic testing for patients with suspected hereditary colorectal cancer syndromes.Entities:
Keywords: Lynch syndrome; MYH-associated polyposis; familial adenomatous polyposis; genetic testing; hereditary colorectal cancer syndromes; hereditary nonpolyposis colorectal cancer
Year: 2015 PMID: 26664327 PMCID: PMC4654621 DOI: 10.1055/s-0035-1564432
Source DB: PubMed Journal: Clin Colon Rectal Surg ISSN: 1530-9681